176 related articles for article (PubMed ID: 30656932)
1. Synthesis and Evaluation of a QS-17/18-Based Vaccine Adjuvant.
Wang P; Škalamera Đ; Sui X; Zhang P; Michalek SM
J Med Chem; 2019 Feb; 62(3):1669-1676. PubMed ID: 30656932
[TBL] [Abstract][Full Text] [Related]
2. Structural Effect on Adjuvanticity of Saponins.
Wang P; Ding X; Kim H; Michalek SM; Zhang P
J Med Chem; 2020 Mar; 63(6):3290-3297. PubMed ID: 32101001
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Evaluation of QS-7-Based Vaccine Adjuvants.
Wang P; Škalamera Đ; Sui X; Zhang P; Michalek SM
ACS Infect Dis; 2019 Jun; 5(6):974-981. PubMed ID: 30920199
[TBL] [Abstract][Full Text] [Related]
4. QS-21 Adjuvant: Laboratory-Scale Purification Method and Formulation Into Liposomes.
Brunner L; Barnier-Quer C; Collin N
Methods Mol Biol; 2017; 1494():73-86. PubMed ID: 27718186
[TBL] [Abstract][Full Text] [Related]
5. Elucidating the Mechanisms of Action of Saponin-Derived Adjuvants.
Marciani DJ
Trends Pharmacol Sci; 2018 Jun; 39(6):573-585. PubMed ID: 29655658
[TBL] [Abstract][Full Text] [Related]
6. QS-21 and QS-7: purified saponin adjuvants.
Kensil CR; Wu JY; Anderson CA; Wheeler DA; Amsden J
Dev Biol Stand; 1998; 92():41-7. PubMed ID: 9554258
[TBL] [Abstract][Full Text] [Related]
7. Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine.
Wu JY; Gardner BH; Murphy CI; Seals JR; Kensil CR; Recchia J; Beltz GA; Newman GW; Newman MJ
J Immunol; 1992 Mar; 148(5):1519-25. PubMed ID: 1538134
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of the quillaja saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systemic responses to recombinant HagB from Porphyromonas gingivalis.
Zhang P; Yang QB; Marciani DJ; Martin M; Clements JD; Michalek SM; Katz J
Vaccine; 2003 Oct; 21(27-30):4459-71. PubMed ID: 14505929
[TBL] [Abstract][Full Text] [Related]
9. Impact of C28 Oligosaccharide on Adjuvant Activity of QS-7 Analogues.
Škalamera Đ; Kim H; Zhang P; Michalek SM; Wang P
J Org Chem; 2020 Dec; 85(24):15837-15848. PubMed ID: 32463234
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure verification of the vaccine adjuvant QS-7-Api. Synthetic access to homogeneous Quillaja saponaria immunostimulants.
Deng K; Adams MM; Gin DY
J Am Chem Soc; 2008 May; 130(18):5860-1. PubMed ID: 18410100
[TBL] [Abstract][Full Text] [Related]
11. Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity.
Marciani DJ; Press JB; Reynolds RC; Pathak AK; Pathak V; Gundy LE; Farmer JT; Koratich MS; May RD
Vaccine; 2000 Jul; 18(27):3141-51. PubMed ID: 10856794
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol.
Fernández-Tejada A; Chea EK; George C; Gardner JR; Livingston PO; Ragupathi G; Tan DS; Gin DY
Bioorg Med Chem; 2014 Nov; 22(21):5917-23. PubMed ID: 25284254
[TBL] [Abstract][Full Text] [Related]
13. Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100.
Marciani DJ; Reynolds RC; Pathak AK; Finley-Woodman K; May RD
Vaccine; 2003 Sep; 21(25-26):3961-71. PubMed ID: 12922132
[TBL] [Abstract][Full Text] [Related]
14. Synthetic studies of complex immunostimulants from Quillaja saponaria: synthesis of the potent clinical immunoadjuvant QS-21Aapi.
Kim YJ; Wang P; Navarro-Villalobos M; Rohde BD; Derryberry J; Gin DY
J Am Chem Soc; 2006 Sep; 128(36):11906-15. PubMed ID: 16953631
[TBL] [Abstract][Full Text] [Related]
15. Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis.
Fernández-Tejada A; Tan DS; Gin DY
Acc Chem Res; 2016 Sep; 49(9):1741-56. PubMed ID: 27568877
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of the potent immunostimulatory adjuvant QS-21A.
Wang P; Kim YJ; Navarro-Villalobos M; Rohde BD; Gin DY
J Am Chem Soc; 2005 Mar; 127(10):3256-7. PubMed ID: 15755124
[TBL] [Abstract][Full Text] [Related]
17. Advances in saponin-based adjuvants.
Sun HX; Xie Y; Ye YP
Vaccine; 2009 Mar; 27(12):1787-96. PubMed ID: 19208455
[TBL] [Abstract][Full Text] [Related]
18. Iscoms containing purified Quillaja saponins upregulate both Th1-like and Th2-like immune responses.
Sjölander A; van't Land B; Lövgren Bengtsson K
Cell Immunol; 1997 Apr; 177(1):69-76. PubMed ID: 9140097
[TBL] [Abstract][Full Text] [Related]
19. Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: A review.
Lacaille-Dubois MA
Phytomedicine; 2019 Jul; 60():152905. PubMed ID: 31182297
[TBL] [Abstract][Full Text] [Related]
20. Oral QS-21 requires early IL-4 help for induction of mucosal and systemic immunity.
Boyaka PN; Marinaro M; Jackson RJ; van Ginkel FW; Cormet-Boyaka E; Kirk KL; Kensil CR; McGhee JR
J Immunol; 2001 Feb; 166(4):2283-90. PubMed ID: 11160283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
